ACME's Global Expansion

Paper Summary:

This paper explains that Pfizer, a continually expanding company, has forged its multinational identity and credibility by working with foreign communities to support initiatives and programs that directly address the environmental issue of health issues in the communities of those regions. ACME feels empowered by the potential demonstrated by the Pfizer example, the author stresses. The short-run costs of expansion initiatives for ACME may seem daunting: however, the paper concludes, the long-term benefits of investing in expansion are clearly visible at Pfizer.

From the Paper:

"In the Pfizer model, we can see further examples of lean production in research and development of pharmaceutical products, ten the means by which the Pfizer expansion has created economic partnerships that optimize their cost efficiency in the same countries that they are bringing the benefits of their products to, and improving the local environment thereof. In effect, Pfizer is both stimulating foreign economy through outsourcing while serving the clinical medical needs of the community, such as in India."

Sample of Sources Used:

• Kindler, Jeff. Strong Actions: Partnering for Positive Change." Pfizer 2007 Corporate Responsibility Report: http://www.pfizer.com/files/corporate_citizenship/cr_report_brochure_2007.pdf
• "Pfizer Driving Performance Through Growth of Current and New Medicines, Productivity Improvements and Strategies to Capitalize on New Market Opportunities." February 10, 2006: http://www.redorbit.com/news/health/385841/pfizer_driving_performance_through_growth_of_current_and_new_medicines/index.html?source=r_health
• "Pfizer harnesses Indian IT strength." 7-22-05: http://www.drugresearcher.com/news/news-ng.asp?n=61476-pfizer-harnesses-indian

More papers on ACME's Global Expansion:

• Term Paper # 101302 : "Acme Overseas Expansion"
• Analytical Essay # 116432 : "Cultural Barriers in Global Expansion"

APA Citation:

MLA Citation: